16395. Adulteration and misbranding of morphia and atropine tablets, chloramine T tablets, potassium bromide tablets, and calcium lactate tablets. U. S. v. The Smith-Dorsey Co. Plea of guilty. Fine, $100 and costs.

Name: 16395. Adulteration and misbranding of morphia and atropine tablets, chloramine T tablets, potassium bromide tablets, and calcium lactate tablets. U. S. v. The Smith-Dorsey Co. Plea of guilty. Fine, $100 and costs.
Creator: National Library of Medicine
Published: 2026-06-21T08:20:20+08:00

Food and Nutrition Information Center2026-06-21 收录

医药监管合规

历史监管执法

数据链接：

https://fdanj.nlm.nih.gov/catalog/fdnj16395 数据链接链接失效反馈

官方服务：

资源简介：

Case Number: 16395 Collection: Foods and Drugs, 1908-1943 Evidence Numbers: F. & D. No. 2-2592. I. S. Nos. 2883-x, 2884-x, 2885-x, 2907-x. Date Issued: December, 1929 Seizure Dates: December 20, 1927 ; January 10, 1928 Product Keywords: morphia and atropine tablets, chloramine T tablets, potassium bromide tablets, and calcium lactate tablets Defendant Names: Smith-Dorsey Co. Court Jurisdiction: District of Nebraska Seizure Location: Missouri Shipped From: Nebraska Shipped To: Missouri Copyright: The National Library of Medicine believes this item to be in the public domain (More information)

提供机构：

National Library of Medicine

16395. Adulteration and misbranding of morphia and atropine tablets, chloramine T tablets, potassium bromide tablets, and calcium lactate tablets. U. S. v. The Smith-Dorsey Co. Plea of guilty. Fine, $100 and costs.

资源简介：

相关数据集